(Press-News.org) Mountains of used plastic bottles get thrown away every day, but microbes could potentially tackle this problem. Now, researchers in ACS Central Science report that they’ve developed a plastic-eating E. coli that can efficiently turn polyethylene terephthalate (PET) waste into adipic acid, which is used to make nylon materials, drugs and fragrances.
Previously, a team of researchers including Stephen Wallace engineered a strain of E. coli to transform the main component in old PET bottles, terephthalic acid, into something tastier and more valuable: the vanilla flavor compound vanillin. At the same time, other researchers engineered microbes to metabolize terephthalic acid into a variety of small molecules, including short acids. So, Wallace and a new team from the University of Edinburgh wanted to expand E. coli’s biosynthetic pathways to include the metabolism of terephthalic acid into adipic acid, a feedstock for many everyday products that’s typically generated from fossil fuels using energy-intensive processes.
The team developed a new E. coli strain that produced enzymes that could transform terephthalic acid into compounds such as muconic acid and adipic acid. Then, to transform the muconic acid into adipic acid, they used a second type of E. coli, which produced hydrogen gas, and a palladium catalyst. In experiments, the team found that attaching the engineered microbial cells to alginate hydrogel beads improved their efficiency, and up to 79% of the terephthalic acid was converted into adipic acid. Using real-world samples of terephthalic acid from a discarded bottle and a coating taken from waste packaging labels, the engineered E. coli system efficiently produced adipic acid. In the future, the researchers say they will look for pathways to biosynthesize additional higher-value products.
The authors acknowledge funding from the Carnegie Trust for the Universities of Scotland; the Industrial Biotechnology Innovation Centre; a Future Leaders Fellowship from UK Research and Innovation; and an Engineering and Physical Sciences Research Council Sustainable Manufacturing grant.
The paper’s abstract will be available on Nov. 1 at 8 a.m. Eastern time here: http://pubs.acs.org/doi/abs/10.1021/acscentsci.3c00414
The American Chemical Society (ACS) is a nonprofit organization chartered by the U.S. Congress. ACS’ mission is to advance the broader chemistry enterprise and its practitioners for the benefit of Earth and all its people. The Society is a global leader in promoting excellence in science education and providing access to chemistry-related information and research through its multiple research solutions, peer-reviewed journals, scientific conferences, eBooks and weekly news periodical Chemical & Engineering News. ACS journals are among the most cited, most trusted and most read within the scientific literature; however, ACS itself does not conduct chemical research. As a leader in scientific information solutions, its CAS division partners with global innovators to accelerate breakthroughs by curating, connecting and analyzing the world’s scientific knowledge. ACS’ main offices are in Washington, D.C., and Columbus, Ohio.
To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org.
Follow us: Twitter | Facebook | LinkedIn | Instagram
END
Plastic-eating bacteria turn waste into useful starting materials for other products
2023-11-01
ELSE PRESS RELEASES FROM THIS DATE:
Younger Middle Eastern patients with new acute coronary syndrome more likely to smoke, have high cholesterol
2023-11-01
Young patients from the Middle East and Gulf region presenting with acute coronary syndrome have a greater prevalence of risk factors, including smoking and high cholesterol compared to older patients also presenting with first acute coronary syndrome. The study, presented at the American College of Cardiology Middle East & Eastern Mediterranean 2023 conference, found these patients still had similar outcomes compared to older patients.
Acute coronary syndrome (ACS) describes a variety of cardiovascular conditions related to sudden reduction in blood flow to the heart, including heart attack and unstable angina ...
Reducing breast cancer disparities in Delaware: 'Getting the village back together'
2023-11-01
There’s a tried and proven pathway to reducing racial disparities in cancer in Delaware. It worked with colon cancer 10 years ago and should now be applied to the incidence of breast cancer in the state. That's the recommendation of clinicians, program leaders and researchers from the ChristianaCare Helen F. Graham Cancer Center & Research Institute in a new commentary published in Population Health Management on Nov. 1, 2023.
The commentary — "Reducing Racial Disparities in Breast Cancer: Getting the ...
New research links high salt consumption to risk of Type 2 diabetes
2023-11-01
Those at risk for Type 2 diabetes may already know to avoid sugar, but new research suggests they may want to skip the salt as well.
A new study from Tulane University published in Mayo Clinic Proceedings found that frequently adding salt to foods was associated with an increased risk of developing Type 2 diabetes.
The study surveyed more than 400,000 adults registered in the UK Biobank about their salt intake. Over a median of 11.8 years of follow-up, more than 13,000 cases of Type 2 diabetes developed among participants. Compared ...
New resource gives business leaders a blueprint for optimizing equitable employee health and well-being
2023-11-01
DALLAS, November 1, 2023 — Health outcomes research has shown that workers in the U.S. experience inequitable health and well-being, with significant variations in the burden of chronic disease, mental health conditions, food insecurity and more across populations, even among those covered by employer-sponsored insurance.[1], [2] Recent studies demonstrate how the workplace can serve as a social driver of health, impacting the risk of conditions such as high blood pressure and heart disease.[3], [4] This growing ...
Nanowire ‘brain’ network learns and remembers ‘on the fly’
2023-11-01
For the first time, a physical neural network has successfully been shown to learn and remember ‘on the fly’, in a way inspired by and similar to how the brain’s neurons work.
The result opens a pathway for developing efficient and low-energy machine intelligence for more complex, real-world learning and memory tasks.
Published today in Nature Communications, the research is a collaboration between scientists at the University of Sydney and University of California at Los Angeles.
Lead ...
Epigenetic signature for obesity found in study of twins
2023-11-01
PULLMAN, Wash. – A susceptibility to gain weight may be written into molecular processes of human cells, a Washington State University study indicates.
The proof-of-concept study with a set of 22 twins found an epigenetic signature in buccal or cheek cells appearing only for the twins who were obese compared to their thinner siblings. With more research, the findings could lead to a simple cheek swab test for an obesity biomarker and enable earlier prevention methods for a condition that effects 50% of U.S. adults, the researchers said.
“Obesity appears to be more complex than simple consumption of food. Our work indicates there’s a susceptibility for this disease ...
Mobile phone use may affect semen quality
2023-11-01
Does electromagnetic radiation emitted by mobile phones affect semen quality? While various environmental and lifestyle factors have been proposed to explain the decline in semen quality observed over the last fifty years, the role of mobile phones has yet to be demonstrated. A team from the University of Geneva (UNIGE), in collaboration with the Swiss Tropical and Public Health Institute (Swiss TPH), has published a major cross-sectional study on the subject. It shows that frequent use of mobile phones is associated with a lower sperm concentration and total sperm count. However, researchers did not ...
Study finds JAK inhibitors, common treatment for arthritis, are effective
2023-11-01
According to a new paper in Rheumatology, published by Oxford University Press, JAK inhibitors, which doctors have used to treat patients with arthritis despite concerns about the effectiveness of such drugs, actually do work quite well. In a multicenter, retrospective study Japanese researchers found that the drugs resulted in impressive remission rates in patients, most of whom choose to continue such treatment.
Rheumatoid arthritis is a common autoimmune disease characterized by chronic inflammation of joint linings and results in progressive joint destruction and other systemic ...
Do mild depressive and anxiety symptoms in fathers predict behavioral and cognitive problems in their children?
2023-11-01
While the role of mothers’ stress, anxiety and depression on children’s behavioral and cognitive development is well established, less is known about the connection between fathers’ mental health and children’s development.
Now, a team of researchers affiliated to different institutions across Quebec, Canada has examined if paternal anxious and depressive symptoms, measured during their partner’s pregnancy, and again six to eight years later, are associated with children’s cognitive function and behavior. They studied this association ...
Cancer drug could hold hope for treating inflammatory diseases including gout and heart diseases
2023-11-01
A cancer drug currently in the final stages of clinical trials could offer hope for the treatment of a wide range of inflammatory diseases, including gout, heart failure, cardiomyopathy, and atrial fibrillation, say scientists at the University of Cambridge.
In a study published today in the Journal of Clinical Investigation, the researchers have identified a molecule that plays a key role in triggering inflammation in response to materials in the body seen as potentially harmful.
We are born with a defence system known as innate immunity, which acts as the first line of defence against harmful materials in the body. Some of these materials will come from outside, such as bacterial or viral ...